Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GenScript introduces Rush Gene Synthesis Service
According to the company, the new service that comes with fast delivery and reduced turnaround time can deliver synthesized genes in five business days, pr-canada.net reported. The company
According to the company, the new service that comes with fast delivery and reduced turnaround time can deliver synthesized genes in five business days, pr-canada.net reported. The company
Neuzym is egg white lysozyme preparation. The application holds good to Neuzym Series’ all six products, pharmalive.com reported. The portfolio of products includes Neuzym Tablets (10 mg, 30
According to the company, the FDA will determine acceptance of filing within 60 days of submission. The application was originally submitted in May 2011, to which FDA issued
Avastin has demonstrated in two phase III studies that women with newly diagnosed advanced ovarian cancer who received Avastin plus chemotherapy and then continued on Avastin alone lived
The approval allows the company to market its Quidel molecular hMPV assay in the US. The company’s molecular product line offers reagents that provide for simple transport and
Following approval, the company will market its influenza A+B assay in the US. Quidel’s product portfolio includes PCR reagent kits for use by molecular diagnostic laboratories with its
Cx611 is a suspension of expanded allogeneic adult stem cells derived from human adipose (fat) tissue that is delivered through intra-venous injection for the treatment of rheumatoid arthritis.
AmiKet (4% amitriptyline, 2% ketamine) is a prescription topical cream intended to treat chemotherapy-induced peripheral neuropathy (CIPN) following taxane-based therapy. EpiCept announced positive results from a study that
As per the deal, Mirna will be responsible for the development and commercialization of any products arising under the agreement and Marina Biotech will support pre-clinical and process
RORgamma, a nuclear hormone receptor, directly controls the production and secretion of the cytokine IL-17, a major contributor to inflammation thereby helping in the treatment of autoimmune diseases